Synthesis and biological evaluation of novel phenothiazine derivatives as non-peptide arginine vasopressin V2 receptor antagonists
被引:0
|
作者:
Shuang Zhi
论文数: 0引用数: 0
h-index: 0
机构:
School of Chemical Engineering and Technology,Tianjin UniversitySchool of Chemical Engineering and Technology,Tianjin University
Shuang Zhi
[1
]
Shuai Mu
论文数: 0引用数: 0
h-index: 0
机构:
School of Chemical Engineering and Technology,Tianjin University
Tianjin Institute of Pharmaceutical ResearchSchool of Chemical Engineering and Technology,Tianjin University
Shuai Mu
[1
,2
]
Ying Liu
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Institute of Pharmaceutical ResearchSchool of Chemical Engineering and Technology,Tianjin University
Ying Liu
[2
]
Min Gong
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Institute of Pharmaceutical ResearchSchool of Chemical Engineering and Technology,Tianjin University
Min Gong
[2
]
Ping-Bao Wang
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Institute of Pharmaceutical ResearchSchool of Chemical Engineering and Technology,Tianjin University
Ping-Bao Wang
[2
]
Deng-Ke Liu
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Institute of Pharmaceutical ResearchSchool of Chemical Engineering and Technology,Tianjin University
Deng-Ke Liu
[2
]
机构:
[1] School of Chemical Engineering and Technology,Tianjin University
A series of novel phenothiazine derivatives was synthesized and tested for arginine vasopressin receptor antagonist activity.They were synthesized as novel arginine vasopressin receptor antagonists from phenothiazine as a scaffold via successive acylation,reduction and acylation reactions.Their structures were characterized by ~1H NMR,C NMR and HRMS,and biological activity was evaluated by in vitro and in vivo studies.The in vitro binding assay indicated that several compounds are potent selective V2 receptor antagonists.Compounds with promising binding affinity to V2 receptors were selected to conduct the in vivo diuretic studies on Sprague-Dawley rats.Among them.In,1r,1t and 1v exhibited excellent diuretic activity,especially 1 rand 1 v.Therefore,1r and 1v are potent novel AVPV2 receptor antagonist candidates.
机构:
Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USAJohnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Matthews, JM
Greco, MN
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Greco, MN
Hecker, LR
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Hecker, LR
Hoekstra, WJ
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Hoekstra, WJ
Andrade-Gordon, P
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Andrade-Gordon, P
de Garavilla, L
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
de Garavilla, L
Demarest, KT
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Demarest, KT
Ericson, E
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Ericson, E
Gunnet, JW
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Gunnet, JW
Hageman, W
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Hageman, W
Look, R
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Look, R
Moore, JB
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
Moore, JB
Maryanoff, BE
论文数: 0引用数: 0
h-index: 0
机构:Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
机构:
Georgetown Univ, Sch Med, Div Endocrinol & Metab, Washington, DC 20007 USAGeorgetown Univ, Sch Med, Div Endocrinol & Metab, Washington, DC 20007 USA